Question 1

What is the catalog number for PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

The catalog number for PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human) is 37567121.

Question 2

What sizes are available for PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human)?

Accepted Answer

PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human) is available in the following size(s): 3x 1.0µg DNA.

Question 3

Is PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human) in stock?

Accepted Answer

PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

PRDM10 CRISPRa sgRNA lentivector (set of three targets)(Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Vector Name

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

Melanoma Marker (HMB45 + M2-7C10 + M2-9E3 + T311), 1mg/mL

Dynamin 3 Rabbit Polyclonal Antibody

S100B (4C4.9), 0.2mg/mL

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF405S conjugate, 0.1mg/mL

Anti-F3

CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) (rKi-1/779), 0.2mg/mL